Free Trial
OTCMKTS:ESMC

Escalon Medical Q3 2025 Earnings Results & Report

Escalon Medical logo
$0.15 0.00 (0.00%)
As of 10/9/2026

Escalon Medical reported Q3 2025 earnings on May 14, 2025. The company reported EPS of $0.02, while revenue was $3.47 million.

Earnings Announcement Details

Quarter
Q3 2025
Report Date
Time
After Market Closes

Escalon Medical EPS Results

Actual EPS
$0.02
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Escalon Medical Revenue Results

Actual Revenue
$3.47 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Escalon Medical Q3 2025 Earnings FAQ

Escalon Medical (OTCMKTS:ESMC) reported earnings of $0.02 per share for Q3 2025. The report was announced on Wednesday, May 14, 2025.

Escalon Medical reported revenue of $3.47 million for Q3 2025.

Escalon Medical Earnings Headlines

Escalon Medical Corp
Trump’s issues shocking Executive Order on U.S. Dollar
Three days into his second term, President Trump signed Executive Order 14178 a move the press barely covered. Buried inside is what some call the legal groundwork for the biggest change to American money in over a century, with a key Treasury vote potentially as soon as January 18. Ian King, Chief Strategist at Strategic Fortunes, breaks down what the order could mean for the dollar and the financial system.tc pixel
Escalon Medical Delays Annual 10-K Filing
See More Escalon Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Escalon Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Escalon Medical and other key companies, straight to your email.

About Escalon Medical

Escalon Medical (OTCMKTS:ESMC) is a medical-device company focused on products for the ophthalmic surgical market. The company develops, manufactures and markets devices and related products used by eye-care professionals, particularly in procedures involving the retina and vitreous.

Its product offerings have included ophthalmic surgical instruments, delivery systems and products used in retinal surgery, such as intraocular gases, silicone oils and other retinal tamponade materials. These products are designed to support procedures for treating retinal detachments and other serious eye conditions.

Escalon Medical has historically served ophthalmic surgeons and medical institutions through markets in the United States and internationally. Publicly available information about the company’s current operations, leadership and geographic reach is limited, and its product portfolio and corporate structure may have changed over time.

View Escalon Medical Profile